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Abstract
Currently, analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) are classified as one of the most emerging group of
xenobiotics and have been detected in various natural matrices. Among them, monocyclic paracetamol and ibuprofen, widely
used to treat mild and moderate pain are the most popular. Since long-term adverse effects of these xenobiotics and their
biological and pharmacokinetic activity especially at environmentally relevant concentrations are better understood, degradation
of such contaminants has become a major concern. Moreover, to date, conventional wastewater treatment plants (WWTPs) are
not fully adapted to remove that kind of micropollutants. Bioremediation processes, which utilize bacterial strains with increased
degradation abilities, seem to be a promising alternative to the chemical methods used so far. Nevertheless, despite the wide
prevalence of paracetamol and ibuprofen in the environment, toxicity and mechanism of their microbial degradation as well as
genetic background of these processes remain not fully characterized. In this review, we described the current state of knowledge
about toxicity and biodegradation mechanisms of paracetamol and ibuprofen and provided bioinformatics analysis concerning
the genetic bases of these xenobiotics decomposition.
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Introduction
Awide range of unique emerging pollutants, including phar-
maceuticals and their metabolites or residues, are continuous-
ly introduced into various environments mainly from hospital
and municipal wastewater, consumer use, or disposal and dis-
charges from pharmaceutical production (Hu et al. 2013;
Zhang et al. 2013; Ebele et al. 2017). Drugs that reach the
environment are mainly excreted in unmodified or slightly
metabolized form, i.e., hydroxylated or conjugated with
charged molecules such as glutathione, glucuronic acid, or
sulfate (Marchlewicz et al. 2015). To date, wastewater treat-
ment plants (WWTPs) are not designed to completely remove
this kind of organic micropollutants, often characterized by
high water solubility and poor biodegradability, which favor
their environmental persistence (Candido et al. 2017).
Moreover, conventional treatment processes, e.g., chlorina-
tion usually results in formation of highly toxic intermediates
(Cao et al. 2016). Nonetheless, for some active compounds,
sewage treatment may eliminate up to 99.9% of their initial
concentration (Chonova et al. 2017). Due to the extremely
diversified structure of micropollutants, their unsaturated/
saturated character, the presence of various functional groups
(e.g., halogen, sulfate), different side chains, and linear or
branched structure, there is no one specific method used in
the sewage treatment for micropollutants utilization.
However, some advanced treatment technologies, enabling a
high removal rate of micropollutants should be highlighted.
Currently, the most important techniques are adsorption on a
powdered activated carbon (PAC) and granular activated car-
bon (GAC), biofiltration including a trickling filter, sand fil-
tration processes, and biological activated carbon (BAC),
nanofiltration, reverse osmosis, membrane bioreactors,
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attached growth technology, and carbon nanocomposites with
magnetic properties ((AC)/CoFe2O4) (Luo et al. 2014; Saucier
et al. 2017). Lack of the optimal treatment technique leads to
the release of many pollutants in their parent form or as active
or more stable metabolites to the environment (Rozas et al.
2016). This could results in their accumulation in trophic
chains and/or long-term adverse effects on aquatic organism
(Grujíć et al. 2009). Some authors highlight that environmen-
tally relevant concentrations (ng/L to μg/L) of residual phar-
maceuticals may not induce negative effects. Although litera-
ture data regarding non-target organism receptors sensitivity,
e.g., primary producers, cnidarians, cladocerans, mussels, or
fish, are scarce, due to the mechanism of pharmaceutical ac-
tion, they can presumably pose a risk for these organisms
(Parolini and Binelli 2012). Oliveira et al. (2015) pointed out
some features of drugs, which may promote their negative
influence on biocoenosis, e.g., high lipophilic character,
which favors the bioaccumulation, low biodegradability,
pseudopersistence, since the rate of pharmaceuticals removal
is compensated by the daily input of new molecules into the
environment. Additionally, drugs are designed as biologically
active molecules, which should be effective in a number of
different species in a slowly metabolized form and their
residues may interact with other pharmaceuticals in natural
matrices. Nevertheless, Nunes et al. (2015) noticed that due
to the conservative nature of the physiological processes and
similarity of target molecules in humans and many aquatic
organisms, some consequences of the continuous contamina-
tion of the environment with pharmaceuticals at the popula-
tion and ecosystem levels are possible to predict. Parolini and
Binelli (2012) warned that high activity of pharmaceuticals
can seriously affect the health status of the biocoenosis.
Moreover, Elersek et al. (2016) noticed that even if individual
concentration of drug is low, the presence of other pharma-
ceuticals with common mode of action might induce additive
or synergistic effects. Thus, in a simple way, environmental
risk calculated on the basis of ecotoxicological data available
for particular drug may result in underestimation of the actual
toxic effect of micropollutants. Additionally, the choice of the
most optimal model for calculation of toxicological effects,
e.g., sigmoid-fitting, concentration addition or independent
action can lead to different results (Elersek et al. 2016). One
of the most prevalent anthropogenic group of xenobiotics,
which have been detected in soil, sediments, and surface,
ground, or even drinking water are analgesics and nonsteroi-
dal anti-inflammatory drugs (NSAIDs). From the environ-
mental point of view, annual production of NSAIDs, which
oscillates around several kilotons, their increasing consump-
tion and prevalence in medicine must be reflected in natural
matrices (Parolini et al. 2011).
Monocyclic over-the-counter NSAIDs, such as ibuprofen,
acetylsalicylic acid, and paracetamol, which share anti-inflam-
matory, analgesic, and antipyretic action, are the most popular
and available drugs among this class. Since aggressive chem-
ical treatment methods, mainly advanced oxidation processes
(AOP) are characterized by harsh reaction conditions and are
not adapted to remove analgesics, bioremediation processes
utilizing bacterial strains with increased abilities to degrade
xenobiotics seem to be a promising alternative. Effectiveness
of selected advanced wastewater treatment methods used in
analgesics and NSAIDs removal are summarized in Table 1.
Biological treatment has been identified as critical to the
degree of micropollutants removal (Falås et al. 2012).
Although, bioremediation processes are the most attractive
and successful clean-up technologies, they are characterized
by some disadvantages. Among them: (1) potential disruption
of bioremediation additives by indigenous microflora, (2) poor
susceptibility of some xenobiotic to biodegradation, (3) almost
impossible removal of genetically modified microorganisms
(GMMs) after bioremediation periods, (4) formation of inter-
mediates characterized by high or indefinite toxicity or persis-
tence, (5) difficulties with extrapolating the lab-scale experi-
ments to field operations, and (6) occurring of contaminations
as solids, gases, or liquids, which frequently impede the biore-
mediation processes should be mentioned. What is equally
important is that microorganisms with increased degradation
abilities often require suitable environmental growth condi-
tions as optimal temperature, pH value, the presence of addi-
tional source of carbon, and appropriate levels of xenobiotics to
induce appropriate enzymes. Additionally, such microorgan-
isms frequently have to be adapted to increasing concentrations
of contaminations, which may extend the bioremediation pro-
cedure (Kumar et al. 2011; Singh and Kumar 2016).
Up to now, several microorganisms able to use paracetamol
and ibuprofen as a sole carbon and energy source have been
described; however, metabolic pathways of biodegradation, es-
pecially for ibuprofen, remain poorly characterized. Two key
metabolites formed during microbial degradation of paraceta-
mol, hydrolytic phenolic dead-end metabolite 4-aminophenol
and hydroquinone, have been identified (Hu et al. 2013; Zhang
et al. 2013). It is also known that microbial degradation of
ibuprofen may proceeds via ligation with coenzyme A and
formation of isobutylcatechol or by direct trihydroxylation of
the aromatic ring, which is prerequisite for further ring cleavage
(Murdoch and Hay 2005; Murdoch and Hay 2013).
The main aim of the study was to summarize the newest
knowledge about occurrence, toxicity, degradation pathways,
and genes encoding enzymes involved in biotransformation/
biodegradation of paracetamol and ibuprofen as the most
emerging contaminants. To complete the overall picture of
degradation processes, it is necessary to perform deep genetic
and molecular analysis, which enables the isolation of mutants
with increased degradation capabilities. The review presents
robust analysis of paracetamol and ibuprofen prevalence in the
environment and their toxicity underling the great importance
of swift and consequent actions to decrease the presence of
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these drugs in the environment mainly by reduction of their
release and efficient biodegradation. Bacterial strains and con-
ditions used in experiments regarding biodegradation of para-
cetamol and ibuprofen as well as the genetic aspect of biodeg-
radation possesses have been described.
Sources of pharmaceuticals
in the environment
Pharmaceuticals occurred in the environment mainly through
the domestic wastewater, hospital effluents, industrial wastewa-
ter from pharmaceuticals production, run-off from aquacultures
and concentrated animals feeding operations, and fish farming
as well as a rural run-off and manure (Luo et al. 2014; Chiarello
et al. 2016; Wiest et al. 2018). In recent years, intensified atten-
tion has been paid to the evaluation of consumer disposal pat-
terns. Studies based on the questions survey showed that signif-
icant percentage of consumers store a large volume of unused
pharmaceuticals and usually dispose of them through municipal
trash. Researchers also highlighted that climatic conditions
regulate pharmaceuticals input in certain periods as well as
administration of a particular drug in common local diseases.
On the other hand, as Vatovec et al. (2017) suggested the in-
crease of social awareness about pro-environment behaviors,
such as purchasing over-the-counter medication in smaller
quantities and utilizing drug take-back programs could signifi-
cantly minimize the growing pollution of environment. The
release of sewage effluents was identified as a main route of
surface waters contamination, since the wide range of pharma-
ceuticals and personal care products (PPCPs) are ubiquitously
detected in treatedwastewater (Luo et al. 2014; Arpin-Pont et al.
2016). Micropollutant contamination of groundwater is caused
mainly by landfill leachate ground and surfacewater interaction,
artificial recharge using reclaimed water, and infiltration of con-
taminated water from agricultural land. Pharmaceuticals present
in solid waste discharge, sewage sludge, or manure fertilizer
may leach from the fields and due to their mobility in the soil
end up in groundwater (Arpin-Pont et al. 2016). Determination
of drugs concentration in drinking water is difficult mainly due
to the limits in quantification (LOQ) and limits in detection
(LOD). Therefore, to study pharmaceutical occurrence in drink-
ing water, advanced analytical techniques should be applied
(Wiest et al. 2018). To date, for most of organic micropollutants,
including paracetamol and ibuprofen, there are no discharges
guidelines and monitoring recommendations. Moreover, syner-
gistic, additive, and antagonistic effects between pharmaceuti-
cals present in the environment are currently completely ignored
(Luo et al. 2014). Since paracetamol and ibuprofen are one of
the most popular over-the-counter drugs, co-occurrence of these
pharmaceuticals in hospital or municipal wastewater as well as
surface waters have been reported. As an example, the Yamuna
River, which is the major tributary of Ganges River, can be
given (Mutiyar et al. 2018). Kosma et al. (2010) reported the
presence of 11 pharmaceuticals including paracetamol and
ibuprofen in the municipal and hospital wastewater treatment
plants of Ioannina City, located inWestern Greece. Ashfaq et al.
(2017a) investigated the occurrence of 11 frequently formulated
drugs in the different environmental matrices near pharmaceu-
tical formulation units of Shiekhupura, Lahore, Pakistan.
Among them, paracetamol and ibuprofen were characterized
by almost the highest detected concentrations. Chinnaiyan et
al. (2018) placed paracetamol and ibuprofen on the list of the
compounds relevant for India as emerging contaminants detect-
ed in water of a developing country examined by considering
the data pertaining to pharmaceutical consumption data.
Monocyclic nonsteroidal anti-inflammatory
drugs
Paracetamol
Occurrence and toxicity
Paracetamol (abbreviated as APAP, IUPAC name N-(4-
hydroxypheny l )e thanamide , ace taminophen , 4 -
acetaminophenol, 4′-hydroxyacetanilide, N-acetyl-p-
aminophenol), is currently one of the most widely used
over-the-counter available antiphlogistic drug worldwide
(Wu et al. 2012; Rhee et al. 2013). Chemically, paracetamol
consists of a benzene ring core substituted by one hydroxyl
group and the nitrogen atom of an amide group at the (1,4)
para position (Bales et al. 1985; Wu et al. 2012). In the UK,
paracetamol is classified in the top three of the most frequently
prescribed drugs. In the USA, where paracetamol is one of the
200 most frequently used pharmaceuticals its consumption
during 2001–2005 reached about 29 billion doses (Li et al.
2014; Marchlewicz et al. 2015). Prevalent occurrence of para-
cetamol, as well as its main degradation product (4-
aminophenol) in the environment, is also partly associated
with their use for manufacturing of azo dyes and photographic
materials (Zhang et al. 2013). Chong et al. (2017) evaluated
consumers’ usage patterns of acetaminophen and according to
the results, majority of consumers use APAP for a headache,
fever, and common pain. Despite the fact that paracetamol is
considered as generally safe, it is one of the most common
drugs responsible for poisoning and liver damage. After ad-
ministration, the majority of paracetamol is rapidly trans-
formed in the liver by the conjugating enzymes urine 5′-
diphosphoglucuronosyltransferase and sulfotransferases
(SULTI A1 and SULTI A3) to the non-toxic compounds,
followed by renal and biliary excretion. The remaining para-
cetamol is oxidized by phase I cytochrome P450 isoenzymes
to the highly reactive and electrophilic metabolite, N-acetyl-p-
benzoquinone-imine (NAPQI). NAPQI is detoxified by
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glutathione (GSH) to form cysteine- and mercapturate-
paracetamol conjugates. With paracetamol overdose, GSH re-
serves are depleted, and as a consequence, NAPQI is accumu-
lated, which results in covalent modification of thiol groups of
proteins, nucleic acids damage, oxidation of membrane lipids,
cell necrosis, and death (Pu et al. 2016; Van Wijk et al. 2017).
The increasing concentrations of paracetamol and other
emerging contaminants result in the possibility of occurrence
of toxic phenomena in non-target species present in receiving
aquatic environments. Recently, the Environment Agency
(EA) of England and Wales, due to the potential risk of pollut-
ants to the aquatic environment, proposed ranking systemwith
the list of the top 10 compounds, where paracetamol have been
classified in 5th place (Ebele et al. 2017). This classification
illustrates general change of approach in the legislation, e.g.,
diclofenac, another NSAIDwith polycyclic aromatic structure,
has been included in the Watch List, which contains the most
important candidates for a supplemented list of priority sub-
stances for the WFD (European Water Framework Directive,
2013). Nunes et al. (2015) highlighted that due to the extreme-
ly high dispersion of paracetamol in nature its environmental
fate and ecotoxicological assessment should be a priority.
Paracetamol has been detected in different environmental
matrices, e.g., surface water at concentrations as high as above
65 μg/L in the Tyne River, England (Roberts and Thomas
2006), higher than 78 μg/L in the Danube River (Grujíć et
al. 2009), in an average concentration of 5 ng/L in different
surface water (Esterhuizen-Londt et al. 2016), 12–64 μg/L
and 1.57–56.9 μg/L in wastewater from Korea, Spain, and
Western Balkan Region (Bosnia and Herzegovina, Croatia,
and Serbia), up to 483 μg/kg in sludge and up to 81 μg/kg
in soil (Luo et al. 2014; Ashfaq et al. 2017a, b). Moreover,
paracetamol easily accumulates in aquatic environment and it
is known to exhibit virtually no sorption nor retardation in
aquifer sand studies (De Gusseme et al. 2011). Even though
the detected concentrations of paracetamol and other NSAIDs
range from nanograms per liter in sewage effluents to micro-
grams per liter in natural waters, a variety of potential negative
effects for these low levels have been described including,
e.g., reproductive or DNA damage, accumulation in tissues,
oxidative stress, lipid peroxidation, and behavioral changes
observed in algae, microcrustaceans, mollusks, or teleost fish
(Islas-Flores et al. 2013; Gómez-Oliván et al. 2014; Minguez
et al. 2016; Islas-Flores et al. 2017) (Table 2). Oliveira et al.
(2015) and Ramos et al. (2014) highlighted that the available
data about the chronic effects and action of pharmaceuticals,
which are calculated for environmentally relevant concentra-
tions showed that most of pharmaceuticals at these levels are
not responsible for lethality. Thus, evaluation of the toxicity
based on sub-lethal endpoint tests will be far better than using
organisms from different trophic levels. Currently, the most
commonly tested biomarkers, which are used as early indica-
tors for even very low concentration of pollutants, are
enzymatic markers of different metabolic pathways, e.g., ox-
idative stress or neuronal function.
The mechanism of paracetamol toxicity seems to be highly
conserved and it is believed to act in the same way in the
vertebrates as in the invertebrates. First, an extremely
important parameter from the ecological point of view
concerns its neurotoxicity. Oliveira et al. (2015) analyzed the
effects of paracetamol on biomarkers of neuronal regulation
and enzymatic oxidative stress defense, including total cholin-
esterases (ChEs), catalase (CAT), glutathione S-transferases
(GSTs), and total and selenium-dependent glutathione peroxi-
dase activities (total GPx; Se-GPx), respectively. As the obtain-
ed results indicated, after exposure to APAP at concentration of
10 μg/L significant inhibition of acetylcholinesterase (AChE)
and Se-GPx activity in Daphnia magna was observed. Similar
results were obtained by Solé et al. (2010) for seawater mussel
Mytilus galloprovincialis after exposure to paracetamol at con-
centration ranging from 0.023 to 0.403 mg/L. It was a first
report of anticholinesterasic effect caused by paracetamol.
Oliveira et al. (2015) noticed that some authors postulate that
enzyme inactivation may be the result of oxidative stress,
which is the most common effect of paracetamol exposure
(Nunes et al. 2015; Ramos et al. 2014). The link between the
oxidation and cholinesterase activity was shown by Weiner et
al. (1994), by proving that oxidative conditions altered the con-
formation of acetylocholinesterase of the fish Torpedo
californica, and Delwing-de Lima et al. (2010), who showed
that neuronal enzymatic biomarkers from rodents could be ox-
idized in vivo. Neurotoxic effect of paracetamol, namely inhi-
bition of AChE activity, was also confirmed by Rhee et al.
(2013) for rotifer species Brachionus koreanus. These results
illustrate quite unexpected neurotoxic effects of well-known
oxidant pharmaceutical pollutions, including paracetamol.
Moreover, Nunes et al. (2015) showed that even a moderate
oxidative stress caused by paracetamol may result in neuro-
transmission impairment in the European eelAnguilla anguilla.
Many authors showed that paracetamol causes the signifi-
cant increase in enzymatic biomarkers involved in cellular re-
dox system, which confirmed that paracetamol triggers oxida-
tive changes. Measurement of glutathione peroxidase activity
(GPx) serves as a biomarker of oxidative stress due to the role
of glutathione enzymes family in removal of some reactive
oxygen species (ROS; mainly hydrogen peroxide and superox-
ide radicals). The second biochemical assay most commonly
used for evaluation of oxidative stress is measurement of cata-
lase activity. However, in studies concerning the oxidative
stress caused by paracetamol a lot of contradictory results have
been published. Oliveira et al. (2015) and Monteiro et al.
(2006) suggested that the decrease in GPx activity after expo-
sure to paracetamol is related to the high amount of the hydro-
peroxide products formed during lipid peroxidation, which ex-
ceeds the antioxidant capacity of GPx. Secondly, the decrease
in GPx activity may be caused by direct inactivation of enzyme
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by reactive metabolites of APAP. The increase in GPx activity
in response to paracetamol exposure has been documented for
Orcheochromis mossambicus (Kavitha et al. 2011), Cyprinus
carpio (Nava-Álvarez et al. 2014), or Dreissena polymorpha,
where the increase of other antioxidant enzyme activity, mainly
catalase and superoxide dismutase, has been observed (Parolini
and Binelli 2012). Nunes et al. (2015) evaluated a battery of
biochemical effects occurring after exposure to paracetamol in
the European eel Anguilla anguilla. As shown in the obtained
results, paracetamol was responsible for the increase in GSTs
activity in the liver, while the CATactivity was not altered. This
suggests that GSTs activity may be related to detoxification
mechanisms, namely conjugation with GSH, which is mainly
responsible for paracetamol excretion. On the other hand, in the
gills, GSTs activity was significantly decreased. Therefore, the
authors suggested that in the combination with the increase in
lipid peroxidation, in the same tissue, the occurrence of mild
oxidative stress cannot be excluded. No changes in the activity
of lactate dehydrogenase (LDH) were reported, which con-
firmed that paracetamol exposure is not related to anaerobic
metabolism. Ramos et al. (2014) evaluated the oxidative stress
caused by paracetamol in a model standard organism rainbow
trout, Oncorhychus mykiss. Tested concentrations of APAP in
acute exposure (96 h) were sub-lethal: 0.00, 0.05, 0.50, and
5.00 mg/L. To test chronic exposure (28 days), tested concen-
trations of APAP were 0.00, 12.5, 25.0, and 50.0 μg/L. As
shown in the obtained results, catalase activity as well as
selenium-dependent and total GPx were increased in both test-
ed periods. Glutathione reductase (GRed) activity was more
strongly expressed after chronic exposure, whereas metabolism
of GSHwas affected after both periods of exposures. In a dose-
dependent manner, a significant increase in lipid peroxidation
was also shown. It is extremely important to notice that oxida-
tive changes and peroxidative damage were observed at
realistic environmental concentrations reported for some
freshwater compartments. As was mentioned above,
GRed activity responsible for the maintenance of cytosolic
physiological concentrations of GSH was increased, which
strongly confirmed that most of the antioxidant defense is
located in the liver.
Ashfaq et al. (2017a, b) evaluated the ecological risk assess-
ment expressed as the ratio between the predicted environmen-
tal concentration (PEC) and measured environmental concen-
tration (MEC) to the predicted no-effect concentrations
(PNEC) of the pharmaceuticals, which generally approximates
the harmful dose of various pharmaceuticals to different spe-
cies living in the aquatic environments. This ratio is considered
in terms of risk quotient (RQ) and hazard quotient (HQ). MEC
is the maximum measured environmental concentration in μg/
L and PNEC is the predicted no-effect concentration (μg/L).
The value of RQ > 1 indicates high risk to the aquatic commu-
nity whereas RQ < 1 indicates medium risk (Bouissou-Schurtz
et al. 2014). For paracetamol, RQ values were about 64, 9.2,
5.0, and 0.11 against daphnia, Streptocephalus proboscideus,
D. magna, and green algae, respectively. These results warrant
high risk of paracetamol against daphnia, S. proboscideus, and
D. magna and the medium risk against green algae.
Guiloski et al. (2017) demonstrated the disruption of
hypothalamic-pituitary-gonadal axis and severe changes of he-
matological parameters, i.e., mild blood congestion, leukocyte
infiltration, and reduction of hemoglobin and hematocrit in
male fish of Rhamdia quelen after exposure to environmental
concentrations of paracetamol in a semi-static bioassay during
21 days. Freitas et al. (2015) investigated the effects of ecolog-
ically relevant concentrations (25 μg/L) of paracetamol on
Polychaete Diopatra neapolitana regenerative tissue capacity.
The obtained results revealed that paracetamol significantly
decrease the regenerative capacity in a dose-dependent man-
ner. Du et al. (2016) showed significant time-dependent and
concentration-dependent adverse effects of paracetamol with
58.3% mortality of D. magna. Moreover, paracetamol caused
50% mortality of D. magna after 21 days of exposure at the
concentration of 5.32 ± 0.32 mg/L. According to the previous
EU Directive 93/67/EEC (Commission of the European
Communities, 1996), which classified chemicals on the basis
of the EC50 values, paracetamol was Bharmful to the aquatic
organisms^ (EC50 concentration between 11 and 100 mg/L)
and Bvery toxic to the aquatic organisms^ (EC50 concentration
< 1 mg/L) after long-term exposure. The currently applicable
legal act regulating the responsibility from public authorities to
industry with regard to assessing andmanaging the risks posed
by chemicals and providing appropriate safety information for
their users is 1907/2006 the European Regulation on
Registration, Evaluation, Authorisation and Restriction of
Chemicals - REACH (Regulation (EC) No 1907/2006).
Biotransformation/biodegradation of paracetamol
Currently, the wastewaters which contain pharmaceuticals are
mainly treated with the advanced oxidation processes (AOP)
including Fenton and photo-Fenton processes, photocatalysis
with titanium dioxide, UV photolysis, or ozonation coupled
with H2O2. The reported efficiency of paracetamol removal in
WWTPs is estimated from almost complete to as high as 86%
for municipal sewage (De Gusseme et al. 2011). Nevertheless,
knowledge about the further fate of paracetamol in the envi-
ronment is still limited. Ahmed et al. (2017) and Glanclément
et al. (2017) summarized the chemical and the biological treat-
ment technologies and reported that a hybrid system based on
ozonation followed by treatment with biological activated car-
bon was found to be the most efficient in the removal of pes-
ticides, beta-blockers, and pharmaceuticals. However, despite
the high efficiency of chemical treatment methods, the high
operational costs, harsh reaction conditions, and formation of
secondary metabolites with high or indefinite toxicity associ-
ated with these methods often make them not a desirable
21506 Environ Sci Pollut Res (2018) 25:21498–21524
choice. Therefore, biodegradation and/or biotransformation of
pharmaceuticals, including NSAIDs, with the use of bacterial
strains with enhanced degradation abilities is a promising en-
vironmentally and economically sustainable tool in wastewa-
ter treatment. The capability of microorganisms to degrade
xenobiotics depends on various environmental factors, affect-
ing degradation processes. It is widely known that temperature
plays an important role in xenobiotics degradation by affecting
bacterial physiology and velocity of enzymatic reaction. The
maximal biodegradation rate of xenobiotics occurs at the tem-
perature of 30–40 °C. At lower temperatures, bacterial mem-
branes become more rigid, as the result in increased viscosity
of membrane phospholipids. On the other hand, at higher tem-
peratures, the membrane transport is frequently hindered as the
result of membrane-associated proteins denaturation. The sec-
ond significant factor, which regulates the degradation of xe-
nobiotics is pH, since it affects microbial cell morphology,
activity, and membrane properties. Through the changes in
ionization of pharmaceuticals molecules, pH may also influ-
ence biosorption and toxicity of pollutants. For paracetamol, at
lower pH, the formation of protonated form (ROH) has been
observed, whereas in alkaline environment paracetamol oc-
curred as phenolate (RO−) form. Since pKa of paracetamol is
9.5, at slightly alkaline environment, APAP is present in the
non-ionic form (Xagoraraki et al. 2008). These allow suppo-
sition that the highest degradation rate of paracetamol may
occur in neutral pH value. This supposition was confirmed
for Pseudomonas moorei KB4 strain, for which the optimal
pH for paracetamol degradation was 7.0 (Żur et al. 2018).
The increased ability to degrade organic micropollutants is
related also with the structure of bacteria cell membranes, i.e.,
the presence of lipopolysaccharide (LPS) and outer membrane
in Gram-negative bacteria as well as specific cell wall architec-
ture in Gram-positive bacteria. Moreover, bacteria are able to
form biofilms embedded with extracellular polymeric sub-
stances (EPS), increasing their protection against harsh environ-
mental conditions, and surface active agents (biosurfactants)
increasing their access to hydrophobic impurities, or specific
enzymes, which are responsible for xenobiotics degradation.
The complexity of polluted environment in a natural way influ-
ences the ability of indigenous and introduced microorganisms
to xenobiotics degradation. The conditions of a particular envi-
ronment must enable microbial growth and activity. As the
bioremediation is a part of whole cell metabolism and results
from the activity of complex microflora present in the polluted
area, it is generally known that the co-occurrence of wide range
of organic pollutants (e.g., PPCPs, lipid regulators, alkylating
agents, hormones) and introduction of an additional carbon
source to the culture may enhance metabolism of xenobiotics
(Kumar et al. 2011; Singh and Kumar 2016). Micropollutants
related factors (e.g., bioavailability, volatility, hydrophobicity,
acidity determined by functional groups, chemisorption, elec-
trostatic adsorption, charge repulsion, the presence of functional
groups donating electrons) in a significant way regulates bio-
degradation processes. Up to now, only a few bacterial strains
able to degrade paracetamol have been isolated (Table 3).
Ahmed et al. (2001) described Pseudomonas sp. ST1 strain
isolated from contaminated sites in Bhai Pheru, Pakistan, being
able to grow on paracetamol and its main degradation interme-
diate, 4-aminophenol, at concentration of 4 g/L as a sole carbon
and energy source and 5 g/L in medium supplemented with
glucose. In the degradation experiments, ST1 strain reduced
777 mg/L of paracetamol during 72 h and 651 mg/L of 4-
aminophenol during 48 h. 4-aminophenol, classified as dead-
end metabolite is characterized by significant nephrotoxicity,
mutagenic and teratogenic effects, and ability to induce DNA
cleavage in mouse and human lymphoma cells. Similar to acet-
aminophen, its first hydrolytic product is poorly biodegradable
and may inhibit degradation metabolic pathway and indirectly
slow down or completely stop the bioremediation processes.
Moreover, for paracetamol, co-contaminants occurring in the
polluted environments, i.e., 4-hydroxybenzoate or 4-
chlorophenol may compete with 4-aminophenol formed during
degradation of paracetamol, since the same enzymes are en-
gaged in degradation of para-substituents (Guzik et al.
2013b). Up to now, only several microorganisms able to de-
grade 4-aminophenol have been described. Several authors re-
ported that 4-aminophenol may be a key metabolite in the mi-
crobial degradation of nitrobenzenes and amines (Takenaka et
al. 2003). Khan et al. (2006) isolated Pseudomonas sp. ST-4
strain able to grow in the presence of 4-aminofenol in the co-
metabolic culture with glucose at concentrations reaching
400 mg/L. The induced by 4-aminophenol cells were later able
to reduce 80% (50 mg/L) of the initial concentration of the
tested compound.
De Gusseme et al. (2011) demonstrated the microbial remov-
al of paracetamol in a membrane bioreactor (MBR), which was
fed with paracetamol at concentration of 100 μg/L (average
20 μg/L of paracetamol per day) as the sole carbon and energy
source for 16 days at a hydraulic retention time (HRT) of 5 days.
After this period, more than 99.9% of the initial paracetamol
concentration was degraded. Microbial consortium in the biore-
actor was also shown to be able to remove paracetamol at envi-
ronmentally relevant concentrations amounting 8.3 μg/L.
Further analysis enable isolation of two paracetamol-degrading
strains identified as Delftia tsuruhatensis and Pseudomonas
aeruginosa. Microbiological degradation of paracetamol was
performed using inoculum with an enriched nitrifying culture
(NEC). The microbial biomass was able to remove paracetamol
at concentration of 100 μg/L continuously at an hydraulic reten-
tion time (HRT) of 1 day. Moreover, batch incubation experi-
ments with heat-inactivated bacteria confirmed that paracetamol
removal was not the result of sorption to the biomass. Further
experiments indicated that there was no influence of the matrix
of aWWTP effluent on APAP degradation and that the biomass
was capable of degrading APAP at environmentally relevant
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concentrations. Inhibited nitrification highlighted the signifi-
cance of the associated heterotrophic bacteria. Moreover, during
microbial degradation of paracetamol by two described isolates,
a brown colorization of synthetic mineral medium was ob-
served, which suggest the formation and/or accumulation of
degradation intermediates, e.g., polymerization products of cat-
echol. Further studies with D. tsuruhatensis strain showed that
themain transformation product—hydroquinone—was also fur-
ther metabolized, mainly due to the oxidative ring opening
which results in loss of chromophoric structure. Hu et al.
(2013) described strain HJ1012 classified as Pseudomonas
aeruginosawhich exhibit ability to degrade paracetamol at con-
centration up to 2.2 g/L and utilize it as the sole carbon and
energy source. Eight intermediates including 4-aminophenol,
hydroquinone, formic acid, lactic acid, oxalic acid, succinic ac-
id, nitrate, and nitrite have been identified. Among them, two
key metabolites of paracetamol degradation 4-aminophenol and
hydroquinone were identified. On the basis of the obtained re-
sults, the authors proposed two different degradation pathway in
HJ1012 strain: (1) the initial hydroxylation of paracetamol
which results in hydroquinone formation with the release of
acetamide and ring opening and (2) the initial decarboxylation
of paracetamol to 4-aminophenol, in which amino group is then
replaced by the hydroxyl group which results in hydroquinone
formation (Fig. 1). The similar catabolic degradation pathways
were suggested by Zhang et al. (2013), who described one strain
from Stenotrophomonas genus (f1 strain) and two
Pseudomonas strains (f2, fg-2) isolated from aerobic aggregate
which use paracetamol as the sole carbon, nitrogen, and energy
source. It is worth to note that so far Stenotrophomonas genus
has not included any known paracetamol degraders. Results
obtained by Zhang et al. (2013) showed that the consortium of
these three microbial strains was able to degrade paracetamol up
to 4 g/L, while pure cultures of f1, f2, and fg-2 strains performed
complete degradation of paracetamol at concentrations of 0.4,
2.5, and 2 g/L, respectively. The authors also noticed that the
consortium achieved substantially higher degradation rates and
significantly better tolerance to paracetamol with a shorter lag
time. The cooperative degradation and mineralization capability
of microbial consortium was also confirmed by oxygen con-
sumption rate. Intermediates identified during paracetamol deg-
radation by GC-MS technique include 4-aminophenol, hydro-
quinone, 2-hexenoic acid, succinic acid, malonic acid, oxalic
acid, formic acid, nitrate, and nitrite. 4-Aminophenol, hydroqui-
none, and pyrocatechol were identified as the key degradation
metabolites of paracetamol degradation pathway in
actinobacteria from Rhodococcus genera in studies performed
by Ivshina et al. (2006). The oxidative deamination of phenolic
intermediates of paracetamol degradation was additionally con-
firmed by De Gusseme et al. (2011), Wu et al. (2012), and
Zhang et al. (2013).
Further degradation of hydroquinone can occur through (1)
cleavage of hydroquinone molecule by hydroquinone 1,2-Ta
bl
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dioxygenase to 4-hydroxymuconic semi-aldehyde and (2) con-
version of hydroquinone to 1,2,4-benzenetriol (hydroxyquinol),
which may be cleaved by hydroxyquinol 1,2-dioxygenase to
maleylacetic acid. The first pathway was proposed for P. moorei
KB4 strain being able to degrade paracetamol at concentrations
as high as 50 mg/L (Żur et al. 2018). The second pathway was
proposed, e.g., by Takenaka et al. (2003) for Burkholderia sp.
AK-5 strain, which utilized 4-aminophenol as the sole carbon,
nitrogen, and energy source. Metabolic pathway of 4-
aminophenol decomposition by AK-5 strain proceeds via
1,2,4-trihydroxybenzene, 1,4-benzenediol, and maleylacetic ac-
id. Li et al. (2014) described the paracetamol degradation path-
way in microorganisms in soil. The proposed mechanism of
decomposition of paracetamol is presumably catalyzed by cy-
tochrome P-450 and proceed via hydroxylation to 3-
hydroxyacetaminophen, which is then oxygenated to N-acetyl-
p-benzoquinone imine or methylation to p-acetanisidide. The
first intermediate is further transformed to para-benzoquinone.
The further conversion of p-acetanisidide includes transforma-
tion to 4-methoxyphenol and in the next step to the 1,4-
dimethoxybenzene. The aromatic structure of the last interme-
diate is probably cleaved by the ring fission enzymes. This
scenario is strongly supported by the presence of 2-hexenoic
acid in the soil extract.
In the last decades, studies on genetic bases of bacterial
degradation of aromatic compounds were focused almost ex-
clusively on aromatic hydrocarbons. Several important plas-
mids like TOL, NAH, or SAL have been identified. The fact
that up to nowmicrobial degradation pathways of naproxen or
diclofenac, two the most commonly used polycyclic NSAIDs
remains not fully described confirmed the severe gap in this
area of knowledge. One of the few genetic experiments
concerning nonsteroidal anti-inflammatory drugs and their
metabolites was performed by Khan et al. (2006). In this
Fig. 1 Biodegradation pathway of paracetamol (Hu et al. 2013; Zhang et al. 2013; Takenaka et al. 2003; Li et al. 2014)
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study, Pseudomonas sp. ST-4 being able to decompose 4-
aminophenol was treated with acridine orange in order to de-
termine the involvement of plasmid-encoded genes in this
xenobiotic degradation, since a wide range of ring cleavage
enzymes has found to be encoded by plasmids. Indeed, ST-4
strain treated with acridine orange became unable to degrade
4-aminophenol, which confirmed that genes involved in bio-
degradation were located on plasmid. Several bacterial strains
f rom Moraxe l la , Pseudomonas , Sphingomonas ,
Burkholderia, Variovorax, Azospirillum, Brachymonas, and
Cupriavidus genera are capable of utilizing hydroquinone,
which may be a product of paracetamol, 4-chlorophenol, 4-
fluoro-, 4-bromo-, 4-iodo-, and 4-nitrophenol degradation
(Enguita and Leitao 2013). Genes encoding enzymes engaged
in degradation of hydroquinone and their regulation were elu-
cidated in the case of 4-nitrophenol-degrading bacterium
Pseudomonas putida DLL-E4. Nine genes are involved in
the degradation of 4-nitrophenol by DLL-E4 strain, specifical-
ly pnpA, pnpR, and pnpC1C2DECX1X2, while pnpC1C2DE
genes are sufficient for transformation of hydroquinone to
tricarboxylic acid cycle metabolites. Additional gene pnpC
encode hydroxyquinol 1,2-dioxygenase, which transform
hydroxyquinol to maleylacetic acid further reduced to beta-
ketoadipate by maleylacetic acid reductase encoded by pnpE.
Regulation of genes involved in 4-nitrophenol degradation by
DLL-E4 is complex. Supplementation of glucose greatly in-
creases 4-nitrophenol degradation, but inhibits degradation of
hydroquinone. Expression of pnpC1C2DECX1X2 operon is
positively regulated by pnpR gene, encoding a LysR-type reg-
ulator, which also positively regulates its own expression and
partially expression of pnpA gene that encode 4-nitrophenol 4-
monooxygenase (Hu et al. 2014; Chen et al. 2016a, b). In
order to better characterize genes involved in hydroquinone
degradation, comparative genomics was performed searching
in NCBI database using BlastP on default settings with E-
value cut-off of 1 × 10−5. Comparative analysis revealed high
conservation of genes order and enabled differentiation of two
distinct gene clusters based on the presence of pnpC gene that
encode hydroxyquinol 1,2-dioxygenase. Lack of this gene
was observed in gene cluster of some, but not all bacteria from
Burkholderia genus. The remaining strains that belong to
Pseudomonas, Cupriavidus, and Burkholderia genera possess
gene pnpE that enables degradation of hydroxyquinol (Fig. 2).
Ibuprofen
Occurrence and toxicity
Ibuprofen (abbreviated as IBU, 2-(4-methylpropyl)phenyl)
propanoic acid) currently is the third most popular NSAID
worldwide. The annual consumption of ibuprofen in selected
EU countries is about 300 t in Germany, 162 t in the UK, and
58 t in Poland (Marchlewicz et al. 2015). In recent years,
increasing intake of ibuprofen was reported for Slovakia,
Czech Republic, and Finland. Relatively low IBU consump-
tion is observed in Norway and Denmark (Hudec et al. 2012).
Ibuprofen is also one of the core drugs in the BEssential Drug
List^ developed in 2010 by World Health Organization
(WHO) (Parolini et al. 2011). Wide prevalence of ibuprofen
and its metabolites in sewage and different natural matrices is
mainly related to the high therapeutic doses ranging from 600
to 1200 mg/day. Orally administrated ibuprofen at therapeutic
doses is rapidly and almost completely (99%) bound to plas-
ma albumin. In human body, up to 15% of ibuprofen is ex-
creted as an unchanged form or glucuronide and thiol conju-
gates or as metabolites, i.e., hydroxyibuprofen (mostly 2-OH
and 3-OH, 1-OH is a minor product), carboxyibuprofen, and
carboxyhydratropic acid, which have no apparent pharmaco-
logical activity. Nevertheless, conjugates of ibuprofen with
glucuronides may be hydrolyzed in the environment
(Marchlewicz et al. 2015; Murdoch and Hay 2015).
Ibuprofen has been found at different concentrations in envi-
ronmental samples, e.g., in wastewater from 45 μg/L in
Canada (Guerra et al. 2014) to 703–1673 μg/L in Pakistan,
1.38 μg/L in South Africa, and 5.78 μg/L in Belgium
(Vergeynst et al. 2015; Ashfaq et al. 2017a), in sludge from
0.009 μg/kg for South Africa (Matongo et al. 2015) to 2053–
6064 μg/kg in Pakistan. Luo et al. (2014) reported presence of
ibuprofen in WWTPs influents in China, Greece, Korea,
Sweden, Switzerland, the UK, and Western Balkan Region
(Bosnia and Herzegovina, Croatia and Serbia) at concentra-
tion range between 0.004 and 603 μg/L. In soil, ibuprofen
concentrations have been detected in the range of 321–
610 μg/kg (Ashfaq et al. 2017a) to 0.213 μg/L for soils irri-
gated with wastewater which contain pharmaceutical residues
(Vazquez-Roig et al. 2012). In surface waters ibuprofen has
been detected at the median concentration of 0.98 μg/L
(Canada), 1.0–67 μg/L (Greece), < 15–414 μg/L (Korea),
5.0–280 μg/L (Taiwan), ND–8.0 μg/L (France), and ND–
1417 μg/L (China) (Almeida et al. 2013; Luo et al. 2014).
According to Luo et al. (2014), the average concentration of
IBU in groundwater for Europe is 3 ng/L, with the maximal
concentration of 395 ng/L. Aymerich et al. (2016) reported the
concentrations of carboxyibuprofen, 1-hydroxyibuprofen, and
2-hydroxyibuprofen in the WWTP influent as 20.24 ± 7.186,
1.091 ± 814, and 7.768 ± 2.693 ng/L, respectively. InWWTPs
sewage containing ibuprofen are mainly treated with AOP,
which results in formation of various metabolites with higher
or indefinite toxicity compared to the parent compounds, e.g.,
1-(4-isobutylphenyl)-1-ethanol, 4-isobutyricbenzaldehyde
(Rácz et al. 2011), 2-[4-(1-hydroxyisobutyl)phenyl] propionic
ac id , 1-e thy l -4 - (1-hydroxy) i sobuty lbenzene , 4-
ethylbenzaldehyde, and 4-ethylphenol (Zheng et al. 2011).
Literature data and knowledge about toxicity and influence
of ibuprofen on aquatic organisms is still limited. Many au-
thors noticed that most of the studies in this field concern
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adverse effects at the highest level of the biological hierarchy,
thereby omitting the sub-organisms level. The observed
changes after acute exposure to IBU in mg/L concentration,
which far exceeds the realistic environmental concentrations,
may suggest that sub-lethal effects are highly probable.
Although the acute toxicity of NSAIDs based on a calculated
short-term EC50, ranging between 10 and 100 mg/L is rather
low, the changes occurring after prolonged exposure to anal-
gesics concerns mainly cyto- and genotoxic effects and imbal-
ance in the oxidative status of cell as well (Parolini and Binelli
2012). Moreover, all further consequences, e.g., growth rate,
reproduction, or behavior result always from the alterations on
the biochemical level. On the other hand, as many authors
highlighted, biochemical alterations and changes in
biomarkers endpoints were more strongly expressed in in
vivo samples compared to samples tested in in vitro
conditions. As Parolini et al. (2011) suggested, living organ-
isms are able to transform parent compound into more toxic
intermediates. Such situation was observed by Kayani et al.
(2009) for ibuprofen conjugated with diacylglycerol (ibupro-
fen-DG), where conjugate was responsible for inhibition of
cell division and nondisjunction in several pairs of
chromosomes. Parolini et al. (2011) demonstrated that chronic
exposure to the environmentally relevant concentrations of
ibuprofen (0.2, 2.0, and 8.0 μg/L) induced moderate genetic
and cellular damage in zebra mussel, Dreissena polymorpha,
a reference biological model sensitive to various pharmaceu-
ticals, including antibiotics. Imbalances in the activity of en-
zymes involved in oxidation processes, namely catalase
(CAT), superoxide dismutase (SOD), glutathione peroxidase,
and the phase II detoxifying enzyme glutathione S-transferase
(GST), clearly showed that ibuprofen causes oxidative stress.
Moreover, authors observed that at the end of exposure to the
highest tested concentration (8 μg/L), the activity of CAT,
SOD, and GPx return to the initial levels. There are two pos-
sible explanations for this state; the balance of the oxidative
status was reached or Dreissena polymorpha adapted to the
changing exposure conditions. Lipid peroxidation and
disorders in the same enzymes activity in zebra mussels were
also reported by Gonzales-Rey and Bebianno (2012) after
7 days of exposure to ibuprofen. Han et al. (2010) investigated
chronic toxicity of ibuprofen for three freshwater species,
Oryzias latipes, Daphnia magna, and Moina macrocopa and
its influence on hormone balance in in vitro conditions using
H295R cell line. Analysis of the results obtained for the cell
line revealed that IBU increased production of 17β-estradiol
and aromatase activity and decreased testosterone production.
Additionally, ibuprofen at concentration of 0.1 μg/L was re-
sponsible for a delay in hatching of eggs inOryzias latipes. De
Lange et al. (2006) revealed that ibuprofen at concentration
ranging from 1 to 100 ng/L decrease activity of amphipod
crustacean Gammarus pulex. Wang et al. (2016) investigated
the influence of IBU at concentrations detected in the environ-
ment on expression of three genes involved in detoxification
processes in D. magna. As shown in the obtained results, the
total amount of eggs and the total number of brood per female
as well as the body length were significantly decreased after
ibuprofen exposure. It was shown that low concentration of
IBU (0.5 μg/L) inhibited expression of two of the analyzed
genes, while increased value of this (50 μg/L) induced their
expression. The third gene expression was inhibited during
short-time exposure (6 h), and induced with prolonged time
(48 h). The increased activities of CAT, SOD, and GST
confirmed occurrence of oxidative stress after IBU exposure.
Saravanan et al. (2012) proposed that changes in hemoglobin,
hematocrit, mean cellular volume, mean cellular hemoglobin,
leukocytes, and plasma glucose and alanine transaminase,
which were increased after exposure to ibuprofen
(14,200 μg/L, 24 h) in an Indianmajor carpCirrhinus mrigala
may serve as potential biomarkers of toxicity of IBU in organ-
isms in receiving aquatic environments. Alterations of blood
parameters and hemocytes after ibuprofen exposure were also
reported for Ruditapes philippinarum (Aguirre-Martínez et al.
2013) and D. polymorpha (Parolini and Binelli 2012). Zanuri
et al. (2017) investigated the influence of ibuprofen on suc-
cessful fertilization of benthos macroinvertebrates, two
Fig. 2 Comparison of pnpC1C2DECX1X2 gene clusters of ten bacterial
strains. Direction of transcription is indicated by arrows. pnpC1, small
subunit of hydroquinone dioxygenase; pnpC2, large subunit of
hydroquinone dioxygenase; pnpD, 4-hydroxymuconic semi-aldehyde
dehydrogenase; pnpE , maleylacetic acid reductase; pnpC ,
hydroxyhydroquinone dioxygenase; pnpX1, YciI family protein; pnpX2,
ferredoxin
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echinoderms Asterias rubens and Psammechinus miliaris and
one polychaete worm species, Arenicola marina. A concen-
trations of ibuprofen detected in a seawater was reported as
0.01–2317 ng/L. As shown in the obtained results, ibuprofen
at these concentrations was responsible for a significant reduc-
tion of fertilization success of P. miliaris, whereas there were
no effects of ibuprofen exposure in oocytes of A. marina and
A. rubens. Toxicity of ibuprofen was also broadly examined
against bacteria, mainly using the Microtox test, which en-
ables evaluation of toxic compounds on bioluminescent
species, Allivibrio fischeri. Di Nica et al. (2017) reported
two significantly diverse IC50 values after 15 min of ibu-
profen exposure, 19.1 and 37.5 mg/L. The negative influ-
ence of ibuprofen widely illustrated on both organisms and
sub-organism level clearly indicates that the need for mon-
itoring environmental relevant concentrations and total
consumption of IBU as well as evaluation of toxicological
data are still valid.
Biotransformation/biodegradation of ibuprofen
Similarly to paracetamol, despite the environmentally relevant
load of ibuprofen, further fate and metabolism of IBU in the
natural matrices remain largely unknown. General structure of
NSAIDs consist of an acidic moiety (carboxylic acid and
enols) attached to a planar, aromatic structure. Some analge-
sics contain also a polar linking group, which attaches the
planar moiety to an additional lipophilic group. Ibuprofen, as
diclofenac, naproxen, ketoprofen, and flurbiprofen possess a
phenylacetic acid core (PAA). Ibuprofen’s structure, i.e., high
branch, the presence of substitutions at the para position of the
aromatic ring and their spatial configuration suggest its high
biodegradation resistance. On the other hand, Parolini et al.
(2011) noticed that IBU due to its physico-chemical properties
may be characterized by high mobility in the aquatic environ-
ments but simultaneously compared to other pharmaceuticals
its persistence is lower. It is widely known that cyclic com-
pounds are less susceptible to biodegradation than the aliphatic
compounds, analogously, polycyclic aromatic compounds are
less vulnerable to degradation than monocyclic one, what is
mainly determined by molecular size. Small molecules are
favor in their straighter carbon chains and spatially organiza-
tion, which promote access to enzymes (Musson et al. 2010).
To date, only a few examples of bacterial decomposition of
ibuprofen have been described.
The first report about the microbial biotransformation of
ibuprofen was described by Chen and Rosazza (1994) for
Nocardia sp. NRRL 5646 strain. Two intermediates formed
from the racemic ibuprofen have been identified as
ibuprofenol and ibuprofen acetate. Further analysis revealed
that the carboxylic acid reductase system responsible for alco-
holic derivatives formation is R(-) enantioselective. Anaerobic
microbial biodegradation of ibuprofen occur through side
chain hydroxylation, which results in carboxyhydratropic acid
and ibuprofenol formation. Murdoch and Hay (2005) summa-
rized the metabolism of the most similar to ibuprofen com-
pounds and identified some patterns (i) meta-cleavage of
cumate (p-isopropylbenzoate) molecule occurring in
Pseudomonas putida F1 strain, where cmt operon carrying
genes encoding most of the enzymes involved in p-cumate
catabolism have been identified; (ii) homoprotocatechuate
pathway for catabolism of L-lysine in Micrococcus
lysodeikticus and Bacillus sp.; (iii) homogentisate degradation
pathway of DL-α-phenylhydracrylic, phenylacetic, and 3- and
4-hydroxyphenylacetic acid in Flavobacterium strain; (iv)
(phenylacetyl)-coenzyme A ligase pathway for Gram-
negative bacteria described as the main route of aerobic degra-
dation of PAA acid; (v) p-hydroxylation of 2-phenylpropionic
acid (2PPA) to 2-(p-hydroxyphenyl)propionic acid (HPPA) de-
scribed in Streptococcus rimosus; and (vi) decarboxylation of
2PPA and tropic acid to yield phenylacetaldehyde and subse-
quent oxidation to phenylacetic acid described in
Pseudomonas cepacia (Sparnins and Chapman 1976; van
den Tweel et al. 1988; Kuge et al. 1991; Andreoni et al.
1992; Eaton 1996; Navarro-Llorens et al. 2005).
Besides studies performed by Chen andRosazzaall attempts
to describe the bacterial catabolic pathway of ibuprofen had to
be based on the studies performed byMurdoch and Hay (2005,
2013). In these studies, the mechanism of microbiological bio-
degradation of IBU was revealed on the basis of
Sphingomonas sp. Ibu-2 strain isolated from wastewater treat-
ment plant able to use both enantiomers of ibuprofen as the
sole carbon and energy source under aerobic conditions
(Fig. 3). Since Ibu-2 is able to remove the propionic acid chain
from ibuprofen and other PAA arylacetic acids, i.e., 2-
phenylpropionic acid, 3- and 4-tolylacetic acids, and 2-(4-
tolyl)propionic acid, to yield catechols or methylocatechols,
extensive biochemical and genetic studies on the mechanism
of this have been performed. In order to reveal the mechanism
of deacylation activity and metabolism of IBU and other PAA
compounds, a fosmid library of Ibu-2 total DNA was con-
structed. Screening the chromosomal library of Ibu-2 DNA
in Escherichia coli EPI300 allowed to identify one fosmid
clone (pFOS3G7) that contained five-gene cluster ipfABDEF,
involved in transformation of ibuprofen to isobutylcatechol.
The ipfA and ipfB genes putatively encode the two subunits
of the aromatic ring of dioxygenase, whereas ipfD was identi-
fied as a gene encoding sterol carrier protein X thiolase. The
ipfF gene shows sequence similarity to genes encoding CoA
ligases, while for ipfE no function was found. Two additional
genes, ipfH and ipfI, were encoding ferredoxin reductase and
components of the aromatic dioxygenase system, respectively.
On the basis of the genetic and previous biochemical analyses,
the authors suggested the following pathway of ibuprofen deg-
radation by Ibu-2 (i) ligation of ibuprofen with CoA by the
CoA ligase IpfF, (ii) dihydroxylation of ibuprofen-CoA by
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the multicomponent oxygenase IpfABHI to yield 1,2-cis-diol-
2-hydroibuprofen CoA, and (iii) removal of acyl-CoA group
by IpfD and IpfE to yield 4-isobutylcatechol (Murdoch and
Hay 2005; Kagle et al. 2009; Murdoch And Hay 2013). To
expand knowledge in aspect of genetic background of ibupro-
fen degradation, we have performed a BlastP search against
NCBI database using protein sequences of the genes from
cluster ipfABDEF on default settings with E-value cut-off of
1 × 10−5. Based on protein sequence similarity and genes ar-
rangement in cluster we identified ipfABDEF cluster in ge-
nomes of ten strains with Sphingomonas sp. Ibu-2 as query
(Fig. 4). Five of the found strains belong to the
Cycloclasticus genus, namely Cycloclasticus zancles 78-ME,
Cycloclasticus sp. DSM 27168, Cycloclasticus pugetii PS-1,
Cycloclasticus sp. P1, and Cycloclasticus sp. PY97M, and are
known for its wide aerobic degradation abilities of polycyclic
aromatic hydrocarbon (PAH) compounds like naphthalene,
phenanthrene, and pyrene. The bacteria of that genus are pre-
dominant PAH-degrading bacteria in marine sediments, sea-
water, and tar (Wang et al. 2008; Messina et al. 2016). The
remaining bacteria with ipfABDEF cluster include
Pseudoxanthomonas spadix BD-a59, Rhodospirillales
bacterium 69-11, Comamonadaceae bacterium SCN 68-20,
Noviherbaspirillum sp. Root189, and Gammaproteobacteria
bacterium TR3.2 which were isolated from gasoline-
contaminated sediment, ammonium sulfate bioreactor, con-
taminated soil, thiocyanate bioreactor, and root of
Arabidopsis thaliana, respectively (Choi et al. 2013; Wattam
et al. 2017). Strain BD-a59 has the ability to degrade benzene,
toluene, ethylbenzene, and o-, m-, and p-xylene, in turn
Fig. 3 Biodegradation pathway of ibuprofen (Chen and Rosazza 1994; Murdoch and Hay 2005; Quintana et al. 2005; Kagle et al. 2009; Murdoch and
Hay 2013; Murdoch and Hay 2015; Marchlewicz et al. 2017b)
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Gammaproteobacteria bacterium TR3.2 has the potential in
degradation of PAH similarly to the strain PY97M which ex-
hibit ability to degrade pyrene and fluoranthene (Choi et al.
2013; Cui et al. 2013; Singleton et al. 2016). The presence of
ipfABDEF cluster in the genomes of these strains suggests their
ability to degrade ibuprofen among other cyclic compounds.
Almeida et al. (2013) described ibuprofen-degrading strain
isolated from activated sludge classified as Gram positive and
assigned to Patulibacter genera. In this study, the authors in-
vestigated the biodegradation of ibuprofen in minimal M9
medium and OD-2 broth and the cellular response of bacteri-
um to ibuprofen using quantitative proteomics with the use of
a metabolic labeling strategy. Performed analysis revealed a
number of proteins which were upregulated even at low con-
centrations of ibuprofen, i.e., acyl-CoA synthetase, one pro-
tein with a Rieske (2Fe-2S) iron-sulfur cluster, which is
known to be involved in the initial oxidation of aromatic ring
and enoyl-CoA hydratase, a well-known enzyme catalyzing
the hydroxylation of double bonds after ring fission. Several
ABC transporter proteins involved in the uptake of the partic-
ular compounds were also upregulated in response to tested
ibuprofen concentrations. Upregulation of ABC transporter
proteins, as well as cytochromes and NADH-dehydrogenases,
have been also showed for Corynebacterium glutamicum and
Pseudomonas sp. KT2440 cells cultivated on benzoate
(Haussmann et al. 2009; Yun et al. 2011), Pseudomonas sp.
KT244 grown on phenol (Roma-Rodrigues et al. 2010), and
Pseudomonas grown in the presence of 4-chlorophenol (Cao
and Loh 2009). Biotransformation of ibuprofen to
trihydroxyibuprofen by the meta-cleavage pathway has also
been showed for Variovorax sp. Ibu-1 strain isolated from
activated sludge by Murdoch and Hay (Murdoch and Hay
2015). While previously characterized degradation ipf path-
way for Ibu-2 strain proceeds via coenzyme A ligation with
subsequent dioxygenation and deacetylation steps, which re-
sults in isobutylcatechol formation, in Variovorax sp. Ibu-1
strain the aromatic ring of ibuprofen undergoes direct
trihydroxylates to the product, which is further utilize as ring
cleavage substrate. The addition with 3-fluorocatechol, a well-
known meta-ring fission enzymes pathway inhibitor, demon-
strated that poly-hydroxylated metabolites of ibuprofen were
only detected when inhibitor was added. It is worth to note
that this was a first study with the use of poison 3-
fluorocatechol, which enables accumulation of short-lived
catecholic intermediates. The same metabolites have been
identified in sewage sludge contaminated with ibuprofen,
which may suggest that meta-ring fission is the most environ-
mentally relevant catabolic pathway of decomposition of ibu-
profen (Toyama 2010; Murdoch and Hay 2015). Moreover,
the authors suggest that trihydroxylated derivatives of ibupro-
fen may serves as a dead-end metabolite. It is worth to note
that hydroxylated and carboxylated derivatives of ibuprofen,
which are characterized by higher toxicity than the parent
compound, have been identified in a number of laboratory
experiments using both ligninolytic fungi and bacteria as well
as physico-chemical processes in WWTPs (Zwiener et al.
2002; Quintana et al. 2005; Murdoch and Hay 2015).
Recently, Marchlewicz et al. (2017b) described a novel
ibuprofen degradation pathway occurring in the Gram-
positive strain, Bacillus thuringiensis B1(2015b) (Fig. 3).
High activity of aliphatic monooxygenases as well as phenol
and hydroquinone monooxygenases confirmed hydroxylation
of both the aromatic ring and aliphatic chain of IBU. GC-MS
analysis revealed the formation of several intermediates, i.e.,
2-hydroxyibuprofen, 2-(4-hydroxyphenyl)-propionic acid,
1,4-hydroquinone, and 2-hydroxyquinol. 1,4-Hydroquinone
as a product of acyl-CoA synthase may be further transform
by hydroquinone monooxygenase to 2-hydroxy-1,4-quinol,
which is favorable bind by hydroxyquinol 1,2-dioxygenase,
an enzyme involved in ortho cleavage of aromatic ring, which
results in 3-hydroxy-cis,cis-muconic acid formation.
Presumably, the final product of ibuprofen degradation is fur-
ther incorporated in central metabolism. It is clear that for all
described studies on the degradation pathways, additional
analyses at environmentally relevant concentrations should
be performed in order to verify if such biochemical pathways
Fig. 4 Comparison of ipfABDEF gene clusters of 11 bacterial strains.
Direction of transcription was indicated by arrows. ipfA, large subunit
of aromatic ring dioxygenase; ipfB, small subunit of aromatic ring
dioxygenase; ipfD, sterol carrier protein X thiolase; ifpE, function
unknown; ipfF, ibuprofen-CoA ligase
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are similar to these observed for artificially high concentra-
tions used in a laboratory scale. It is also worth to mention that
Marchlewicz et al. (2017b) observed interesting relationship
between removal of ibuprofen and pH medium value. The
highest removal efficiency was observed at pH 7.2, whereas
in a slightly higher pH (8.0), significant inhibition of ibupro-
fen biodegradation was observed. Possible explanation con-
cerns a functional state of proteins involved in a decomposi-
tion of ibuprofen, since at the pH higher than 6.5, IBU occurs
in an anionic form (pKa 4.3). This excludes the hypothesis
about the low electrostatic interaction between molecules
and binding sites present on the biomass surface. At low and
high pH value (suboptimal conditions), the growth of micro-
organisms is significantly altered (low biomass is related with
low degradation capabilities). pH value also affects the activ-
ity of degradation enzymes. For example, in B1 strain at pH
8.0, two enzymes engaged in ibuprofen degradation, phenol
monooxygenase, and catechol 1,2-dioxygenase showed their
maximal activity. The lower activity of hydroquinone
monooxygenases at pH 8.0 was probably connected with the
loss of the FADmolecule, which is observed for this molecule
above pH 7.5. The biodegradation of ibuprofen was examined
also in the presence of various co-contaminants. As shown in
the obtained results, degradation of ibuprofen by Bacillus
thuringiensis B1(2015b) strain was enhanced in the presence
of phenol, benzoate, and 2-chlorophenol. Simultaneously, re-
moval of phenol and benzoate was also observed. On the other
hand, introduction of 4-chlorophenol into the culture
completely inhibited degradation of ibuprofen (Marchlewicz
et al. 2017a, b).
Potential application of enzymes involved
in NSAIDs degradation in bioremediation
and industry
Degradation strategies of aromatic compounds involve hy-
droxylation catalyzed by monooxygenases or hydroxylation
dioxygenases and subsequent aromatic ring fission.
Hydroxylation results in several key intermediates formation
such as catechol, protocatechuic acid, gentisic acid, or
hydroquinol, which are substrates for oxidative ring cleavage
catalyzed by dioxygenases. Two families of dioxygenases,
intradiol which catalyzes ortho cleavage and extradiol which
catalyzes meta-cleavage, diversified in terms of structure and
mechanics, can be distinguished (Melo et al. 2010; Guzik et al.
2013b). Enzymes involved in biotransformation and/or bio-
degradation of aromatic compounds, including NSAIDs, may
be applied in bioremediation and industrial processes due to
their resistance to various inhibitors, i.e., metal ions, organic
solvents, phenols, or hydrocarbons. To date, direct application
of extracted enzymes in the catalytic environmental processes
has been limited mainly due to the significant decrease in
enzymes activity and potential poisoning or blockage of the
enzymes active site. Strategies which allow improving en-
zymes stability and properties include medium engineering,
cross-linking with chemical compounds, protein engineering,
or immobilization. Since products of ortho ring fission are
widely applicable as substrates for chemical synthesis, their
role in industry seems to be essential. Currently, one of the
major scopes in the field of catalysis is to develop low-cost
systems using suitable reusable catalysts that are permanently
immobilized on a solid support and are able to perform
different cycles of catalysis. Di Nardo et al. (2009)
immobilized catechol 1,2-dioxygenase from Acinetobacter
radioresistens S13 strain able to convert catechol to cis,cis-
muconate (ccMA) and subsequent adipic acid on β-
cyclodextrins cross-linked with carbonate nanosponges. As
shown in the results, the immobilization modified the activity
profile of enzyme mainly changes of the optimal pH and tem-
peratures. Compared to the free enzyme thermostability and
residual activity of the immobilized enzyme was significantly
increased. The usefulness of catechol 1,2-dioxygenase in
adipic acid production has also been shown by Guzik et al.
(2013a). In this study, a highly active enzyme being able to
produce methyl derivatives of cis,cis-muconic acid was isolat-
ed from the environmental strain Stenotrophomonas
maltophilia KB2. A catA gene encoding catechol 1,2-
dioxygenase was identified in strains able to convert cis,cis-
muconic acid and was used to produce great amounts of this
acid by recombinant Escherichia coli cells carrying gene from
Pseudomonas putida mt-2 (Kaneko et al. 2011). Han et al.
(2015) reconstructed a new synthetic pathway of ccMA pro-
duction by regulating the constitutive expression of catechol
1,2-dioxygenase from the Acinetobacter sp. ADP1 strain. The
tenfold greater enzyme activity was possible to achieve due to
the mutations in the protein structure. The ring fission by the
ortho pathway and activity of catechol 1,2-dioxygenase and
phenol hydroxylation enzymes were also shown in filamentous
fungi from Fusarium, Aspergillus, Penicillium, and Graphium
genera, which suggest their application in the treatment of phe-
nol contaminated areas (Santos and Linardi 2004). Dos Santos
et al. (2009) studied degradation of phenol by immobilized and
free Aspergillus pullulans FE13 cells. Despite the loss of cate-
chol 1,2-dioxygenase activity, alginate-immobilized cells, after
immobilization cells remained viable for a longer period, and
increased the efficiency of phenol degradation was observed.
Zucolotto et al. (2006) developed a highly sensitive biosensor
for detection of catechol derived from pesticides and other
industrial wastewater degradation. Chlorocatechol 1,2-
dioxygenase (CCD) was immobilized in nanostructured films
interleaved with poly(amidoamine) dendrimer in a layer-by-
layer manner. The results showed that immobilization did not
affect the CCD activity and obtained films were able to detect-
ed catechols even at a concentration of 10−19 M. Catechol 1,2-
dioxygenase was also isolated from Sphingomonas xenophaga
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QYY (Guo et al. 2009) and Rhodococcus opacus 1CP (Matera
et al. 2010). Dioxygenase isolated from R. opacus 1CP and
named Rho 1,2-CCD was shown to be able to degrade cate-
chols and its methylated and chlorinated derivatives as well as
protocatechuate. Chlorocatechol dioxygenases due to the steric
and electron distribution in the large active site are found to be
capable of utilizing a broad range of aromatic compounds,
including methylated derivatives of catechol (Melo et al.
2010). In the study performed by Zhang et al. (2017),
protocatechuate 3,4-dioxygenase (P34O), isolated from
Rhizobium sp. LMB-1 was covalently bound to supermagnetic
(3-Aminopropyl) triethoxysilane (3-APTES)-modified Fe3O4
nanopar t ic les us ing the glutara ldehyde method.
Immobilization of P34O greatly increased its properties, i.e.,
thermostability, kinetic parameters, and reusability. Metabolic
pathway proceeds via protocatechuate 3,4-dioxygenase ring
fission is also used to production of beta-ketoadipic acid and
muconolactone from aromatic compounds related to lignin,
which are recently useful in production of industrial chemicals
such as muconic acid, polyhydroxyalkanoate, or guaiacol
(Okamura-Abe et al. 2016). Mycroft et al. (2015) inserted
genes encoding protocatechuate 4,5-dioxygenase and
protocatechuate 2,3-dioxygenase to aromatic lignin-degrading
strain Rhodococcus jostii RHA1. It resulted in formation of
aromatic pyridine-dicarboxylic acids used for bioplastic syn-
thesis. The presence of microorganisms with high catechol 2,3-
dioxygenase activity was detected in oxygen limited environ-
ment contaminated with aromatic hydrocarbons (Táncsics et
al. 2015). Hydroxyquinol 1,2-dioxygenase is a well-known
enzyme involved in chlorobenzene, aminophenols, and
nitrophenols degradation. As Guzik et al. (2013b) and
Takenaka et al. (2003) noticed during degradation of such
components, hydroxyquinol is a key intermediate; thus, en-
zymes being able to decompose it play the important role in
their biodegradation. Recombinant hydroxyquinol 1,2-
dioxygenase derived from Arthrobacter chlorophenolicus A6
immobilized on single-walled carbon nanotubes using physical
adsorption and covalent bounding by Suma et al. (2016) was
characterized by increased temperature range and resistance to
harsh environmental factors, i.e., ionic strength.
Conclusions
Despite the widespread use of analgesic paracetamol and
NSAID ibuprofen and, consequently, their unintended pres-
ence in the environment, the mechanisms of biological degra-
dation and their genetic bases remain poorly understood.
Therefore, the need for isolation and characterization of new
bacterial strains being able to degrade paracetamol and ibu-
profen is still valid. Further research in biodegradation area
should be focused on development of highly effective treat-
ment systems, e.g., by immobilization ofmicroorganismswith
increased metabolic properties, which will combine the high
removal rate and low-cost options. The second most pressing
aspect of analgesic degradation concerns the unraveled genet-
ic bases of degradation abilities, e.g., identification of genes,
operons, and regulation of their expression. Obtaining mu-
tants, metagenomics studies, sequencing of whole bacterial
genomes, and comparative genomics are most often used for
those purposes. On the other hand, enzymes responsible for
the increased degradation of xenobiotics are often isolated and
used for various industrial processes.
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